Windlas Biotech Ltd posts Rs. 12.06 crores consolidated net profit in Q1 FY2023-24

Windlas Biotech Ltd has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 147.410 crores during the period ended June 30, 2023 as compared to Rs. 143.047 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 12.065 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 11.444 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 5.79 for the period ended June 30, 2023 as compared to Rs. 5.37 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 147.410 crs	₹143.047 crs	3.05%
Net Profit	₹12.065 crs	₹11.444 crs	5.43%
EPS	₹5.79	₹5.37	7.82%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 147.410 crores during the period ended June 30, 2023 as compared to Rs.122.794 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.12.065 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.9.80 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.5.79 for the period ended June 30, 2023 as compared to Rs.4.50 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 147.410 crs	₹122.794 crs	20.05%
Net Profit	₹12.065 crs	₹9.80 crs	23.11%
EPS	₹5.79	₹4.50	28.67%

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 329.30 as compared to the previous close of Rs. 318.25. The total number of shares traded during the day was 23360 in over 1283 trades.

The stock hit an intraday high of Rs. 337.05 and intraday low of 324.05. The net turnover during the day was Rs. 7758314.00.

Source : Equity Bulls

Keywords

WindlasBiotech Q1FY24 ResultUpdate